Table 2.
Sensitivity analysis for strength as a predictor of limited physical performance and for low ALM as a predictor of low strength across subgroups in the Canadian longitudinal study on aging cohort, 2011–2015
N | Prevalence low HGS (%) | OR (95% CI) for impaired physical performance | P for interactiona | OR (95% CI) for low HGS | |||
---|---|---|---|---|---|---|---|
Low HGS | Prevalence low ALM (%) | Low ALM | P for interactionb | ||||
Men | |||||||
Overall | 4725 | 21.5 | 4.51 (3.58, 5.68) | 21.7 | 3.02 (2.59, 3.52) | ||
Age | |||||||
65–74 | 2878 | 14.8 | 4.50 (2.87, 7.04) | 0.162 | 16.3 | 2.71 (2.14, 3.43) | 0.777 |
≥75 | 1847 | 32.0 | 3.09 (2.34, 4.07) | 30.0 | 2.59 (2.10, 3.19) | ||
Nutritional risk (SCREEN II‐AB) | |||||||
Yes | 1332 | 24.2 | 3.09 (2.34, 4.07) | 0.304 | 22.1 | 3.79 (2.87, 5.00) | 0.058 |
No | 3393 | 20.5 | 4.50 (2.89, 7.04) | 21.5 | 2.74 (2.28, 3.30) | ||
Heart disease | |||||||
Yes | 1029 | 25.4 | 4.79 (3.17, 7.24) | 0.640 | 21.4 | 2.79 (2.04, 3.84) | 0.558 |
No | 3696 | 20.4 | 4.25 (3.21, 5.62) | 21.8 | 3.11 (2.61, 3.71) | ||
Kidney disease | |||||||
Yes | 173 | 28.9 | 2.74 (0.97, 7.76) | 0.339 | 28.9 | 4.47 (2.19, 9.10) | 0.264 |
No | 4552 | 21.2 | 4.61 (3.64, 5.84) | 21.4 | 2.95 (2.52, 3.45) | ||
COPD | |||||||
Yes | 273 | 26.0 | 3.55 (1.54, 8.20) | 0.565 | 30.4 | 3.39 (1.92, 5.99) | 0.667 |
No | 4452 | 21.2 | 4.58 (3.61, 5.82) | 21.1 | 2.98 (2.54, 3.49) | ||
Type 2 diabetes | |||||||
Yes | 630 | 27.6 | 4.21 (2.57, 6.90) | 0.853 | 19.7 | 4.01 (2.66, 6.05) | 0.163 |
No | 4095 | 20.6 | 4.44 (3.41, 5.76) | 22.0 | 2.93 (2.48, 3.45) | ||
Women | |||||||
Overall | 4363 | 24.1 | 4.66 (3.67, 5.92) | 13.7 | 2.46 (2.05, 2.95) | ||
Age | |||||||
65–74 | 2706 | 15.4 | 5.43 (3.39, 8.70) | 0.013 | 11.5 | 2.44 (1.86, 3.21) | 0.483 |
≥75 | 1657 | 38.2 | 2.69 (2.02, 3.58) | 17.3 | 2.14 (1.65, 2.76) | ||
Nutritional risk (SCREEN II‐AB) | |||||||
Yes | 1427 | 27.4 | 2.69 (2.02, 3.58) | 0.867 | 14.0 | 2.07 (1.51, 2.81) | 0.168 |
No | 2936 | 22.4 | 5.43 (3.39, 8.70) | 13.5 | 2.70 (2.16, 3.37) | ||
Heart disease | |||||||
Yes | 519 | 28.7 | 3.01 (1.77, 5.11) | 0.081 | 12.7 | 2.52 (1.49, 4.26) | 0.947 |
No | 3844 | 23.4 | 5.11 (3.90, 6.70) | 13.8 | 2.47 (2.03, 2.99) | ||
Kidney disease | |||||||
Yes | 142 | 31.0 | 3.30 (1.25, 8.67) | 0.480 | 16.9 | 0.70 (0.26, 1.91) | 0.012 |
No | 4221 | 23.8 | 4.72 (3.69, 6.05) | 13.6 | 2.58 (2.15, 3.10) | ||
COPD | |||||||
Yes | 318 | 27.4 | 3.31 (1.64, 6.66) | 0.314 | 15.7 | 2.22 (1.18, 4.15) | 0.736 |
No | 4045 | 23.8 | 4.85 (3.75, 6.26) | 13.5 | 2.48 (2.05, 3.00) | ||
Type 2 diabetes | |||||||
Yes | 376 | 27.4 | 4.48 (2.41, 8.34) | 0.909 | 8.0 | 2.93 (1.38, 6.24) | 0.663 |
No | 3987 | 23.8 | 4.66 (3.59, 6.05) | 14.2 | 2.47 (2.05, 2.98) |
ALMI, appendicular lean mass index; COPD, chronic obstructive pulmonary diseases; HGS, handgrip strength; SCREEN II‐AB, abbreviated Seniors in the Community Risk Evaluation for Eating and Nutrition, version II, score < 38 was considered as at risk of poor nutritional state.
Interaction for absence/presence of low HGS and subgroup characteristics in the prediction of impaired physical performance.
Interaction for absence/presence of low ALM and subgroup characteristics in the prediction of low HGS.